Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2013

01-09-2013 | Stanford Multidisciplinary Seminars

Hepatic Abscess with Biliary Communication Following Transarterial Chemoembolization of Hepatocellular Carcinoma

Authors: Robert J. Huang, Andrew P. Ambrosy, George Triadafilopoulos

Published in: Digestive Diseases and Sciences | Issue 9/2013

Login to get access

Excerpt

The patient is a 78-year-old female immigrant from Vietnam with a history of chronic hepatitis B virus (HBV) infection, whose initial complaint was progressive weight loss and jaundice over several months. Triphasic computed tomography (CT) revealed the presence of numerous hepatic lesions demonstrating arterial hypervascularity and delayed venous washout, characteristic of hepatocellular carcinoma (HCC), with associated extra- and intra-hepatic biliary dilation and choledocholithiasis. Her alpha-fetoprotein level was also elevated at 104 ng/mL. Additional imaging did not reveal any extrahepatic metastasis. …
Literature
1.
2.
3.
Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50–57.PubMedCrossRef
4.
5.
Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol JVIR. 2001;12:313–320.CrossRef
6.
Sakamoto I, Aso N, Nagaoki K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics. 1998;18:605–619.PubMed
7.
Huang SF, Ko CW, Chang CS, Chen GH. Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor. Hepatogastroenterology. 2003;50:1115–1118.PubMed
8.
Chen C, Chen PJ, Yang PM, et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997;92:2257–2259.PubMed
9.
Ong GY, Changchien CS, Lee CM, et al. Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3,878 procedures. Eur J Gastroenterol Hepatol. 2004;16:737–742.PubMedCrossRef
Metadata
Title
Hepatic Abscess with Biliary Communication Following Transarterial Chemoembolization of Hepatocellular Carcinoma
Authors
Robert J. Huang
Andrew P. Ambrosy
George Triadafilopoulos
Publication date
01-09-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2593-1

Other articles of this Issue 9/2013

Digestive Diseases and Sciences 9/2013 Go to the issue

Original Paper

Catechins in Dietary Supplements and Hepatotoxicity

Original Article

Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer

Original Article

Comparison of Performance and Safety of Endoscopic Retrograde Cholangiopancreatography Across Pediatric Age Groups

Case Report

Gallbladder Metastatic Combined Hepatocellular Carcinoma and Cholangiocarcinoma Without Primary Intrahepatic Tumor

Erratum

Erratum to: Role of Nociceptors/Neuropeptides in the Pathogenesis of Visceral Hypersensitivity of Nonerosive Reflux Disease

Original Article

Angiotensin II Induces Endothelin-1 Expression in Human Hepatic Stellate Cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits